Article
PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
The Journal of pathology - 1 Aug 2023
Choi Sangjoon, Kim Hyunjin, Heo You Jeoung, Kang So Young, Ahn Soomin, Lee Jeeyun, Kim Kyoung-Mee
Abstract excerpt
PIK3CA mutations in cancer regulate tumour immunogenicity. Given that PIK3CA mutation subtypes influence therapeutic responses to AKT inhibitor and that H1047R mutation confers selective growth advantages after immunotherapy, we hypothesised that immune phenotypes may depend on PIK3CA mutation subtypes. We investigated 133 gastric cancers (GCs) harbouring PIK3CA mutation [21 E542K (15.8%), 36 E545X (27.1%), 26...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
